← FDA DRUG APPROVALS

FDA ANDA · ANDA076963

PILOCARPINE HYDROCHLORIDE

Sponsor: INNOGENIX

APPLICATION
ANDA076963
TYPE
ANDA
ORIGINAL APPROVAL
2004-12-22
LATEST ACTION
2020-08-26
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

PILOCARPINE HYDROCHLORIDEPrescription
PILOCARPINE HYDROCHLORIDE 5MG · TABLET · ORAL
PILOCARPINE HYDROCHLORIDEPrescription
PILOCARPINE HYDROCHLORIDE 7.5MG · TABLET · ORAL

Approval history

2020-08-26Labeling · Supplement 9 · standardAP
2008-01-16Labeling · Supplement 5AP
2007-02-27Labeling · Supplement 1AP
2007-02-27Manufacturing (CMC) · Supplement 2AP
2004-12-22OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →